Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$46,186,454
+$37,442,201 QoQ
Shares Held
38,507
+305.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#573
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 15%
Shared 0%
None 85%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisors Capital Management, LLC holds $495,472,264 across 11 Drug Manufacturers - General names. LLY ranks #5 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
526,560 | $133,730,443 | |
| 2 | ABBV |
AbbVie Inc.
|
505,318 | $127,158,221 | |
| 3 | PFE |
Pfizer Inc
|
2,703,246 | $65,094,163 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,029,843 | $59,339,553 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
38,507 | $46,186,454 | |
| 6 | AMGN |
Amgen Inc
|
73,921 | $26,768,272 | |
| 7 | MRK |
Merck & Co., Inc.
|
179,565 | $23,074,102 | |
| 8 | NVS |
Novartis AG
|
57,958 | $9,083,177 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,186,454 | 38,507 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $8,744,253 | 9,507 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $10,378,185 | 9,657 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $8,050,413 | 10,551 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $7,733,717 | 9,921 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $8,793,463 | 10,647 | Shares | Sole | 2025-05-27 | |
| 2024-12-31 | $8,023,396 | 10,393 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,552,845 | 5,139 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,403,307 | 5,968 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,655,769 | 7,270 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,455,549 | 5,928 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,853,234 | 5,312 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,381,011 | 5,077 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,617,164 | 4,709 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,855,174 | 5,071 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,503,254 | 4,649 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $1,488,539 | 4,591 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,331,047 | 4,648 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,280,555 | 4,636 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,016,620 | 4,400 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $973,164 | 4,240 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $766,148 | 4,101 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $561,393 | 3,325 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $483,877 | 3,269 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $479,241 | 2,919 | Shares | Sole | 2020-08-18 | |
| 2020-03-31 | $388,416 | 2,800 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||